Vaccine Confidence Toolkit Resource Guide: Chapter 2
Learn important steps in identifying and engaging with communities at risk for vaccine-preventable diseases in culturally competent ways to manage vaccine hesitancy, particularly during outbreaks.
Infographic: How to Support COVID-19 Vaccination Decisions in Native American Communities
How to support COVID-19 vaccination decisions in Native American communities infographic.
Infographic: How to Support COVID-19 Vaccination Decisions in Latinx Communities
How to support COVID-19 vaccination decisions in Latinx communities infographic.
Infographic: How to Support COVID-19 Vaccination Decisions in African American Communities
How to support COVID-19 vaccination decisions in African American communities infographic.
Myocarditis and the Pfizer and Moderna COVID-19 Vaccines
This talking points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide information on the few cases of myocarditis reported in individuals who received the Pfizer or Moderna COVID-19 vaccines.
COVID-19 Omicron (B.1.1.529) Variant
This talking points document was developed by the iREACH Subject Matter Experts to provide information on the COVID-19 Omicron variant.
Resources on updated COVID-19 boosters for everyone 6 months and older
On December 9, 2022, the CDC (following authorization by the FDA), CDC expanded the use of updated (bivalent) COVID-19 booster vaccines for children ages 6 months through 5 years. Learn more here.
AIM: Fertility, Pregnancy, and COVID-19 Vaccines Talking Points
This talking points document was developed by iREACH Subject Matter Experts to provide information on fertility, pregnancy and COVID-19 vaccines.
COVID-19 Booster Dose Update (AIM)
This talking points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide updated information on COVID-19 vaccine booster doses.
First Approved Oral Antiviral Pill for COVID-19 Disease
This talking points document, available in Spanish and English, was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide detailed information on the first approved oral antiviral pill for COVID-19 disease.